Piperlongumine induces apoptosis and G2/M phase arrest in human osteosarcoma cells by regulating ROS/PI3K/Akt pathway
Authors:
- 1 June 2020
- journal article
- research article
- Published by Elsevier in Toxicology in Vitro
- Vol. 65, 104775
Abstract
No abstract availableKeywords
Funding Information
- Zhejiang Province Natural Science Foundation
This publication has 47 references indexed in Scilit:
- MicroRNA-21 accelerates hepatocyte proliferation in vitro via PI3K/Akt signaling by targeting PTENBiochemical and Biophysical Research Communications, 2014
- Overview of the therapeutic potential of piplartine (piperlongumine)European Journal of Pharmaceutical Sciences, 2013
- Insulin-like growth factor-1 induces the phosphorylation of PRAS40 via the PI3K/Akt signaling pathway in PC12 cellsNeuroscience Letters, 2012
- Selective killing of cancer cells by a small molecule targeting the stress response to ROSNature, 2011
- Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal boneBritish Journal of Cancer, 2010
- Biological activity of dihydroartemisinin in canine osteosarcoma cell linesAmerican Journal of Veterinary Research, 2008
- Therapy for OsteosarcomaPediatric Drugs, 2008
- Antiplatelet effects of acidamides isolated from the fruits of Piper longum L.Phytomedicine, 2007
- Piplartine, an amide alkaloid from Piper tuberculatum, presents anxiolytic and antidepressant effects in micePhytomedicine, 2007
- Cell survival, cell death and cell cycle pathways are interconnected: Implications for cancer therapyDrug Resistance Updates, 2007